bis(1,2-bis(diphenylphosphino)ethane)gold(i) has been researched along with EHS Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berners-Price, SJ; Crooke, ST; Faucette, LF; Johnson, RK; Mattern, MR; McCabe, FL; Mirabelli, CK; Mong, SM; Sadler, PJ; Sung, CM | 1 |
1 other study(ies) available for bis(1,2-bis(diphenylphosphino)ethane)gold(i) and EHS Tumor
| Article | Year |
|---|---|
In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Cisplatin; Copper; Copper Sulfate; DNA; Gold; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Nucleic Acids; Organogold Compounds; Organometallic Compounds; Organophosphorus Compounds; Protein Biosynthesis; Sarcoma, Experimental | 1986 |